Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn Guymer

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Clinical Trials (London, England)|August 31, 2025
Automated data collection from an electronic medical record for a prospective real-world study in patients with retinal disease (VOYAGER)Clare Bailey, Ian Pearce, Christiana Dinah, et al.
Clinical & Experimental Ophthalmology|June 20, 2019
Development and validation of a deep-learning algorithm for the detection of neovascular age-related macular degeneration from colour fundus photographsStuart Keel, Zhixi Li, Jane Scheetz, et al.
Retina (Philadelphia, Pa.)|February 2, 2017
TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONDaniel Barthelmes, Vuong Nguyen, Vincent Daien, et al.
Ophthalmology|December 3, 2013
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMark C Gillies, Richard J Walton, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Free Radical Biology & Medicine|September 26, 2018
Dual roles of different redox forms of complement factor H in protecting against age related macular degenerationMatthew Krilis, Miao Qi, Jian Qi, et al.
Scientific Reports|July 24, 2020
Systemic lipid dysregulation is a risk factor for macular neurodegenerative diseaseRoberto Bonelli, Sasha M Woods, Brendan R E Ansell, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Experimental Eye Research|June 2, 2022
New approaches to the treatment of Age-Related Macular Degeneration (AMD)Karl Csaky, Christine A Curcio, Robert F Mullins, et al.
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Clinical Trials (London, England)|August 31, 2025
Automated data collection from an electronic medical record for a prospective real-world study in patients with retinal disease (VOYAGER)Clare Bailey, Ian Pearce, Christiana Dinah, et al.
Clinical & Experimental Ophthalmology|June 20, 2019
Development and validation of a deep-learning algorithm for the detection of neovascular age-related macular degeneration from colour fundus photographsStuart Keel, Zhixi Li, Jane Scheetz, et al.
Retina (Philadelphia, Pa.)|February 2, 2017
TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONDaniel Barthelmes, Vuong Nguyen, Vincent Daien, et al.
Ophthalmology|December 3, 2013
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMark C Gillies, Richard J Walton, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Free Radical Biology & Medicine|September 26, 2018
Dual roles of different redox forms of complement factor H in protecting against age related macular degenerationMatthew Krilis, Miao Qi, Jian Qi, et al.
Scientific Reports|July 24, 2020
Systemic lipid dysregulation is a risk factor for macular neurodegenerative diseaseRoberto Bonelli, Sasha M Woods, Brendan R E Ansell, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Experimental Eye Research|June 2, 2022
New approaches to the treatment of Age-Related Macular Degeneration (AMD)Karl Csaky, Christine A Curcio, Robert F Mullins, et al.
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Pageof 9